UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study

Leukemia research, 2024-07, Vol.142, p.107529, Article 107529

2024

Volltextzugriff (PDF)

Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis

Leukemia research, 2024-09, Vol.144, p.107563, Article 107563

2024

Volltextzugriff (PDF)

De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features

Leukemia research, 2022-06, Vol.117, p.106857-106857, Article 106857

2022

Volltextzugriff (PDF)

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Leukemia research, 2014-07, Vol.38 (7), p.751-755

2014

Volltextzugriff (PDF)

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

Leukemia research, 2018-10, Vol.73, p.51-57

2018

Volltextzugriff (PDF)

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

Leukemia research, 2007-06, Vol.31 (6), p.727-736

2007

Volltextzugriff (PDF)

Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study

Leukemia research, 2023-02, Vol.125, p.107006, Article 107006

2023

Volltextzugriff (PDF)

The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes

Leukemia research, 2015-01, Vol.39 (1), p.6-17

2015

Volltextzugriff (PDF)

Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN

Leukemia research, 2024-07, Vol.142, p.107518, Article 107518

2024

Volltextzugriff (PDF)

Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)

Leukemia research, 2019-09, Vol.84, p.106194-106194, Article 106194

2019

Volltextzugriff (PDF)

Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years

Leukemia research, 2017-05, Vol.56, p.88-95

2017

Volltextzugriff (PDF)

MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients

Leukemia research, 2023-11, Vol.134, p.107386-107386, Article 107386

2023

Volltextzugriff (PDF)

Over-expression of CD200 predicts poor prognosis in MDS

Leukemia research, 2017-05, Vol.56, p.1-6

2017

Volltextzugriff (PDF)

The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T

Leukemia research, 2022-01, Vol.112, p.106757-106757, Article 106757

2022

Volltextzugriff (PDF)

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes

Leukemia research, 2012-06, Vol.36 (6), p.727-734

2012

Volltextzugriff (PDF)

MYC overexpression is associated with an early disease progression from MDS to AML

Leukemia research, 2021-12, Vol.111, p.106733-106733, Article 106733

2021

Volltextzugriff (PDF)

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia

Leukemia research, 2018-09, Vol.72, p.79-85

2018

Volltextzugriff (PDF)

Incidence of myelodysplastic syndromes in Finland 1997–2016

Leukemia research, 2022-05, Vol.116, p.106839-106839, Article 106839

2022

Volltextzugriff (PDF)

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

Leukemia research, 2023-08, Vol.131, p.107340-107340, Article 107340

2023

Volltextzugriff (PDF)

The classification of MDS: From FAB to WHO and beyond

Leukemia research, 2012-12, Vol.36 (12), p.1453-1458

Vardiman, James

2012

Volltextzugriff (PDF)

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

Leukemia research, 2012-08, Vol.36 (8), p.1067-1070

2012

Volltextzugriff (PDF)

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

Leukemia research, 2017-06, Vol.57, p.78-84

2017

Volltextzugriff (PDF)

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Leukemia research, 2023-11, Vol.134, p.107390-107390, Article 107390

2023

Volltextzugriff (PDF)

Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis

Leukemia research, 2019-05, Vol.80, p.11-18

2019

Volltextzugriff (PDF)

Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

Leukemia research, 2017-01, Vol.52, p.50-57

2017

Volltextzugriff (PDF)

1 – 25 von 1.043

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLeukemia Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.043)
Mit Volltextzugriff
(1.042)

Publikationsform

Artikel
(1.043)

Sprache

Englisch
(1.043)

Erscheinungsjahr

n.n

Thema

Humans
(979)
Hematology
(960)
Oncology
(959)
Life Sciences & Biomedicine
(957)
Science & Technology
(957)
Male
(556)
Female
(553)
Middle Aged
(504)
Aged
(499)
Hematology, Oncology And Palliative Medicine
(485)
Adult
(388)
Myelodysplastic Syndromes - Genetics
(358)
Myelodysplastic Syndromes
(332)
Myelodysplastic Syndromes - Pathology
(327)
Aged, 80 And Over
(312)
Myelodysplastic Syndrome
(303)
Biological And Medical Sciences
(232)
Prognosis
(232)
Medical Sciences
(231)
Myelodysplastic Syndromes - Drug Therapy
(225)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.043)
Ingenta
(1.043)
Elsevier ScienceDirect Journals Complete
(1.043)
MEDLINE
(986)
IngentaConnect Journals
(498)

Zeitschrift / Serie

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study

Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis

De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study

The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes

Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN

Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)

Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years

MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients

Over-expression of CD200 predicts poor prognosis in MDS

The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes

MYC overexpression is associated with an early disease progression from MDS to AML

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia

Incidence of myelodysplastic syndromes in Finland 1997–2016

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

The classification of MDS: From FAB to WHO and beyond

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis

Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

Aktive Filter

Suchergebnisse filtern